Principal Financial Group
SRNE

Principal Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Principal Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-106,183
Closed -$94.1K – 2523
2022
Q4 		$94.1K Buy
106,183
+22,657
+27% +$30.1K ﹤0.01% 2298
2022
Q3 		$131K Buy
83,526
+17,128
+26% +$38.9K ﹤0.01% 2281
2022
Q2 		$133K Sell
66,398
-19,266
-22% -$33.3K ﹤0.01% 2358
2022
Q1 		$200K Buy
85,664
+1,614
+2% +$5.03K ﹤0.01% 2340
2021
Q4 		$391K Sell
84,050
-26,662
-24% -$166K ﹤0.01% 2185
2021
Q3 		$845K Buy
110,712
+3,575
+3% +$30.3K ﹤0.01% 2051
2021
Q2 		$1.04M Sell
107,137
-3,212
-3% -$25.6K ﹤0.01% 2027
2021
Q1 		$913K Sell
110,349
-5,966
-5% -$63K ﹤0.01% 2014
2020
Q4 		$793K Buy
116,315
+46,454
+66% +$373K ﹤0.01% 1997
2020
Q3 		$778K Buy
69,861
+3,962
+6% +$36.3K ﹤0.01% 1918
2020
Q2 		$414K Buy
65,899
+29,195
+80% +$112K ﹤0.01% 2008
2020
Q1 		$67K Buy
36,704
+736
+2% +$2.12K ﹤0.01% 2143
2019
Q4 		$122K Buy
35,968
+4,028
+13% +$9.6K ﹤0.01% 2179
2019
Q3 		$68K Buy
31,940
+3,788
+13% +$8.83K ﹤0.01% 2201
2019
Q2 		$75K Sell
28,152
-47,869
-63% -$172K ﹤0.01% 2195
2019
Q1 		$361K Sell
76,021
-445
-0.6% -$1.17K ﹤0.01% 1998
2018
Q4 		$183K Sell
76,466
-16,112
-17% -$52.6K ﹤0.01% 2149
2018
Q3 		$408K Buy
92,578
+4,628
+5% +$25.7K ﹤0.01% 2006
2018
Q2 		$633K Buy
+87,950
New +$598K ﹤0.01% 1921

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
Oaktree Capital Management
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Principal Financial Group's SRNE Position: Q1 2023 in Review

Principal Financial Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 106,183 shares — an estimated $94.1K sold.

Principal Financial Group first reported a position in SRNE in Q2 2018 and held it in 19 quarters. The position peaked at $1.04M in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Principal Financial Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Principal Financial Group sold 106,183 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $94.1K.
  • Principal Financial Group first reported a position in Sorrento Therapeutics, Inc. in Q2 2018 and held it in 19 quarters.
  • Principal Financial Group's Sorrento Therapeutics, Inc. position peaked at $1.04M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Principal Financial Group's 13F filing for Q1 2023, filed 9 May 2023.